Health Canada approves Aspen Pharmacare generic semaglutide injection

Reuters2026/07/20 14:30

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Health Canada granted Aspen approval for Aspen-Semaglutide, a generic semaglutide injectable for adults with type 2 diabetes.
Commercial rollout hinges on semaglutide API supply from Dr. Reddy's Laboratories, which has flagged temporary supply constraints.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspen Pharmacare Holdings Ltd. published the original content used to generate this news brief via SENS, the regulatory disclosure system operated by the Johannesburg Securities Exchange (JSE) (Ref. ID: S524353), on July 20, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Health Canada approves Aspen Pharmacare generic semaglutide injection

You may also like

Crypto prices